Spots Global Cancer Trial Database for Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
Official Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With Gastric Cancer(ALTER0503)
Study ID: NCT02461407
Conditions
Study Description
Brief Summary: The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China
Beijing Cancer Hospital, Beijing, Beijing, China
The 307th Hospital of Chinese People's Liberation Army, Beijing, Beijing, China
Chongqing Daping Hospital, Chongqing, Chongqing, China
Union Hospital of Fujian Medical University, Fuzhou, Fujian, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Lanzhou General Hospital, Lanzhou, Gansu, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Fourth Hospital of Hebei Medical University Tumor Hospital of Hebei Province, Shijiazhuang, Hebei, China
Harbin medical university affiliated tumor hospita, Harbin, Heilongjiang, China
Henan Province Tumor Hospital, Luoyan, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
Xiangya Hospital Central South University, Changsha, Hunan, China
The Third Xiangya Hospital Central South University, Changsha, Hunan, China
Hunan Province Tumor Hospital, Changsha, Hunan, China
The General Hospital of Nanhua University, Hengyang, Hunan, China
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Nantong Cancer Hospital, Nantong, Jiangsu, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
Jilin Cancer Hospital, Changchun, Jilin, China
Liaoning Province Tumor Hospital, Shenyang, Liaoning, China
Shandong Tumor Hospital, Jinan, Shandong, China
Linyi City Tumor Hospita, Linyi, Shandong, China
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
Shanghai General Hospital, Shanghai, Shanghai, China
Cancer Hospital of Fudan University, Shanghai, Shanghai, China
Tangdu Hospital of The fourth Military Medical University, Xian, Shanxi, China
Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Yunnan Province Tumor Hospital, Kunming, Yunnan, China
Sir Run Run Shaw Hospital School of Medical,Zhejiang University, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
